Controlled transgene expression by E1-E4-defective adenovirus vectors harbouring a "tet-on" switch system

Journal of Gene Medicine

Volumn 4, Issue 6, 2002, Pages 668-675

  Fender, P ^a,c   Jeanson, L ^a,d   Ivanov, M A ^a   Colin, P ^b   Mallet, J ^b   Dedieu, J F ^a   Latta Mahieu, M ^a  

^a SANOFI   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^d IGR UMR 8532 16   (France)

Author keywords

E1 E4 defective adenovirus vectors; rtTA synthesis; Tet on regulation

Indexed keywords

ADENOVIRUS VECTOR; DOXYCYCLINE; LUCIFERASE; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN; REPRESSOR PROTEIN; TETRACYCLINE RESISTANCE ENCODING TRANSPOSON REPRESSOR PROTEIN; TETRACYCLINE RESISTANCE-ENCODING TRANSPOSON REPRESSOR PROTEIN; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL CULTURE; CELL LINE; CELL STRAIN; CONTROLLED STUDY; CORPUS STRIATUM; CYTOMEGALOVIRUS; FEMALE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE TISSUE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEFECT; PROTEIN EXPRESSION; RAT; TRANSGENE; VIRUS GENE; VIRUS RECOMBINANT; ADENOVIRUS; ANIMAL; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; HUMAN; METABOLISM; MUSCLE; SPRAGUE DAWLEY RAT;

ADENOVIRIDAE; CUCUMBER MOSAIC VIRUS;

ADENOVIRIDAE; ANIMALS; CORPUS STRIATUM; GENETIC VECTORS; HUMANS; MICE; MUSCLES; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINATION, GENETIC; REPRESSOR PROTEINS; THYMIDINE KINASE; TRANSGENES;

EID: 1642497091     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.315     Document Type: Article

References (25)

1. Bohn MC, Choi-Lundberg DL, Davidson BL, et al. Adenovirus-mediated transgene expression in nonhuman primate brain. Hum Gene Ther 1999; 10: 1175-1184.
2. Choi-Lundberg DL, Lin Q, Chang YN, et al. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 1997; 275: 838-841.
3. Qin L, Ding Y, Pahud DR, et al. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther 1997; 8 1365-1374.
4. Yang Y, Nunes FA, Berencsi K, et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci 1994; 91: 4407-4411.
5. Yeh P, Dedieu JF, Orsini C, et al. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J Virol 1996; 70: 559-565.
6. Wang Q, Greenburg G, Bunch D, et al. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector. Gene Ther 1997; 4: 393-400.
7. Gao GP, Yang Y, Wilson JM. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol 1996; 70: 8934-8943.
8. Dedieu JF, Vigne E, Mafhouz I, et al. Long term delivery into the livers of immunocompetent mice with E1/E4 defective adenoviruses. J Virol 1997; 71: 4626-4637.
9. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci 1992; 89: 5547-5551.
10. Gossen M, Freundlieb S, Bender G, et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
11. Rossi F, Guicherit O, Spicher A, et al. Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat Med 1999; 20: 389-393.
12. Crouzet J, Naudin L, Orsini C, et al. Recombinational construction in E. coli of infectious adenoviral genomes. Proc Natl Acad Sci 1997; 94: 1414-1419.
13. Blanche F, Cameron B, Barbot A, et al. An improved anion-exchange HPLC method for the detection and purification of adenoviral particles. Gene Ther 2000; 7: 1055-1062.
14. Steinwaerder DS, Lieber A. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo. Gene Ther 2000; 7: 556-567.
15. Forster K, Helbl V, Lederer T, et al. Tetracycline-inducible expression systems with reduced basal activity in mammalian cells. Nucleic Acids Res 1999; 27: 708-710.
16. Deuschle U, Meyer WK, Thiesen HJ. Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol 1995; 15: 1907-1914.
17. Bohl D, Naffakh N, Heard JM. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat Med 1997; 3: 299-305.
18. Corti O, Horellou P, Colin P, et al. Intracerebral tetracycline-dependent regulation of gene expression in grafts of neural precursors. Neuroreport 1996; 7: 1655-1659.
19. Ridet JL, Corti O, Pencalet P, et al. Toward autologous ex vivo gene therapy for the central nervous system with human adult astrocytes. Hum Gene Ther 1999; 10: 271-280.
20. Corti O, Sanchez-Capelo A, Colin P, et al. Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. Proc Natl Acad Sci 1999; 96: 12 120-12 125.
21. Hu SX, Ji W, Zhou Y, et al. Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression. Cancer Res 1997; 57: 3339-3343.
22. Mizuguchi H, Hayakawa T. Characteristics of adenovirus-mediated tetracycline-controllable expression system. Biochim Biophys Acta 2001; 1568: 21-29.
23. Harding TC, Geddes BJ, Murphy D, et al. Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system. Nat Biotechnol 1998; 6: 553-555.
24. Smith-Arica JR, Morelli AE, Larregina AT, et al. Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression. Mol Ther 2000; 6: 579-587.
25. Urlinger S, Baron U, Thellmann M, et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci 2000; 14: 7963-7968.